Figure - PMC

Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2019 Feb 15.

Published in final edited form as: Cancer. 2017 Dec 6;124(4):688–697. doi: 10.1002/cncr.30967

Figure 1. — Kaplan-Meier Plots for Progression Free and Overall Survival by Treatment Arm, 1a. The Cox regression models for PFS for the two comparisons revealed the following hazard ratios: TS-H IROX/Bev (arm A) vs TS-H FOLFOX/Bev (arm B) 1.2 (95% CI 0.8–1.7, P=0.41) and TS-H FOLFOX/Bev (arm B) vs TS-L FOLFOX/Bev (arm C) 1.6 (95% CI 1.0–2.4, P=0.04). 1b. Cox regression models for OS revealed the following hazard ratios: TS-H IROX/Bev vs TS-H FOLFOX/Bev 1.4 (95% CI 0.9–2.1, P=0.15) and TS-H FOLFOX/Bev vs TS-L FOLFOX/Bev 1.6 (95% CI 1.0–2.4, P=0.07).

Figure 1. — Kaplan-Meier Plots for Progression Free and Overall Survival by Treatment Arm, 1a. The Cox regression models for PFS for the two comparisons revealed the following hazard ratios: TS-H IROX/Bev (arm A) vs TS-H FOLFOX/Bev (arm B) 1.2 (95% CI 0.8–1.7, P=0.41) and TS-H FOLFOX/Bev (arm B) vs TS-L FOLFOX/Bev (arm C) 1.6 (95% CI 1.0–2.4, P=0.04). 1b. Cox regression models for OS revealed the following hazard ratios: TS-H IROX/Bev vs TS-H FOLFOX/Bev 1.4 (95% CI 0.9–2.1, P=0.15) and TS-H FOLFOX/Bev vs TS-L FOLFOX/Bev 1.6 (95% CI 1.0–2.4, P=0.07).